“Budget Impact Analysis of Apixaban Versus Other NOACs for the Prevention of Stroke in Italian Atrial Fibrillation Patients”. 2014. Farmeconomia. Health Economics and Therapeutic Pathways 15 (1S): 5-14. https://doi.org/10.7175/fe.v15i1s.973.